Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more

Published 1 month ago Positive
Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more
Auto
Here's a list of key deals reported across sectors this week:

* STAAR Surgical (NASDAQ:STAA [https://seekingalpha.com/symbol/STAA]) said in a presentation that its $28.00 per share all-cash merger [https://seekingalpha.com/news/4499588-staar-surgical-pushes-for-all-cash-merger-with-alcon] with Alcon provides its stockholders compelling, certain cash value at a significant premium across multiple measures.
* Pfizer (NYSE:PFE [https://seekingalpha.com/symbol/PFE]) has agreed to acquire [https://seekingalpha.com/news/4496839-pfizer-nears-73b-takeover-of-weight-loss-drugmaker-metsera-ft-reports] Metsera (NASDAQ:MTSR [https://seekingalpha.com/symbol/MTSR]) in a deal worth $47.50 per share in cash, valuing the company at $4.9 billion upfront, with the potential for shareholders to receive up to an additional $22.50 per share through contingent value rights.
* Canada's Dentalcorp Holdings (TSX:DNTL:CA [https://seekingalpha.com/symbol/DNTL:CA]) has agreed [https://seekingalpha.com/news/4499454-dentalcorp-to-be-acquired-by-investment-funds-affiliated-with-gtcr-in-c22b-all-cash-deal] to be acquired by private equity firm GTCR in an all-cash deal valuing the company at C$2.2 billion in equity terms.
* DB Insurance to acquire [https://seekingalpha.com/news/4499366-db-insurance-to-acquire-us-based-insurer-fortegra] 100% of the outstanding shares of The Fortegra Group, a U.S.-based specialty insurer, for approximately $1.65 billion in cash from Tiptree (NASDAQ:TIPT [https://seekingalpha.com/symbol/TIPT]) and Warburg Pincus.
* Rocket Lab (NASDAQ:RKLB [https://seekingalpha.com/symbol/RKLB]) has agreed [https://seekingalpha.com/news/4499337-rocket-lab-to-acquire-mynaric-ag-for-150m] with Mynaric to purchase all of the issued and outstanding shares of the German laser communication developer for $75M.
* Integral Ad Science (NASDAQ:IAS [https://seekingalpha.com/symbol/IAS]) shares surged nearly 20% premarket on Wednesday after the company entered into a definitive agreement to be acquired [https://seekingalpha.com/news/4498314-integral-ad-science-to-go-private-in-1030share-all-cash-deal] by private equity firm Novacap in an all-cash transaction.
* Axon Enterprise (NASDAQ:AXON [https://seekingalpha.com/symbol/AXON]) on Tuesday said it signed an agreement to acquire [https://seekingalpha.com/news/4497865-axon-to-acquire-emergency-communications-platform-prepared] Prepared, a U.S.-based emergency communications company.
* Hitachi (OTCPK:HTHIY [https://seekingalpha.com/symbol/HTHIY]) has agreed to acquire [https://seekingalpha.com/news/4497524-hitachi-to-acquire-german-data-and-ai-services-firm-synvert] German data and AI services firm synvert from private equity fund Maxburg.
* Strive (NASDAQ:ASST [https://seekingalpha.com/symbol/ASST#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]) said Monday it has agreed to buy [https://seekingalpha.com/news/4497056-strive-to-acquire-fellow-bitcoin-treasury-firm-semler-scientific-in-all-stock-deal] Semler Scientific (NASDAQ:SMLR [https://seekingalpha.com/symbol/SMLR#hasComeFromMpArticle=false#source=section%3Amain_content%7Cbutton%3Abody_link%7Cfirst_level_url%3Anews]) in an all-stock deal that combines the two bitcoin (BTC-USD [https://seekingalpha.com/symbol/BTC-USD]) treasury companies.

MORE ON M&A TICKERS, ETC.

* Pfizer: Buy The Pharma Giant Following The Metsera Deal [https://seekingalpha.com/article/4826009-pfizer-buy-the-pharma-giant-following-the-metsera-deal]
* Pfizer: Invest For The Yield, Not The Weight-Loss Drug Chase [https://seekingalpha.com/article/4825980-pfizer-invest-for-the-yield-not-the-weight-loss-drug-chase]
* Axon Is Outgrowing Its Critics And That's Why It's A Clear Buy For Me [https://seekingalpha.com/article/4825820-axon-is-outgrowing-its-critics-and-thats-why-its-a-clear-buy-for-me]
* Investment banks weigh in on impact of new pharma tariffs on drugmakers [https://seekingalpha.com/news/4499587-investment-banks-weigh-in-impact-new-pharma-tariffs-drugmakers]
* STAAR Surgical pushes for all-cash merger with Alcon [https://seekingalpha.com/news/4499588-staar-surgical-pushes-for-all-cash-merger-with-alcon]